Claims for Patent: 6,080,541

Summary for Patent: 6,080,541

Title:	Method for producing tagged genes, transcripts, and proteins
Abstract:	The invention described here is a method whereby a molecular tag is put on a gene, transcript and protein in a single recombinational event. The protein tag takes the form of a unique peptide that can be recognized by an antibody or other specific reagent, the transcript tag takes the form of the sequence of nucleotides encoding the peptide that can be recognized by a specific polynucleotide probe, and the gene tag takes the form of a larger sequence of nucleotides that includes the peptide-encoding sequence and other associated nucleotide sequences. The central feature of the invention in its essential form is that the tag-creating DNA has a structure such that when it is inserted into an intron within a gene it creates two hybrid introns separated by a new exon encoding the protein tag. A major virtue of the method is that it allows one to identify new proteins or protein-containing structures, and, having done so, to readily identify and analyze the genes encoding those proteins.
Inventor(s):	Jarvik; Jonathan W. (Pittsburgh, PA)
Assignee:
Application Number:	08/901,097
Patent Claims:	1. A method for identifying and purifying a tagged protein, said tagged protein being tagged according to a method for tagging genes, transcripts and proteins in eucaryotic cells, comprising: (1) producing a tagged gene by inserting a DNA sequence into an intron of a gene by: (a) selecting a DNA sequence: (i) having a 5' portion free of any nucleotide sequence selected from the group consisting of CAGGTAAGT, CAGGTGAGT, AAGGTAAGT, AAGGTGAGT, followed by; (ii) a nucleotide sequence selected from the group consisting of TACTAAC, TGCTAAC, TCCTAAC, TTCTAAC, TACTGAC, TGCTGAC, TCCTGAC, TTCTGAC and TACTAAC and any nucleotide sequence identical to a known splice branch site in a known gene, followed by; (iii) a sequence selected from the group consisting of a sequence 14 to 34 nucleotides in length and any nucleotide sequence identical in length to a known spacer region between splice branch and acceptor sites in a known gene, followed by; (iv) a nucleotide sequence selected from the group consisting of CAGG, TAGG, and any sequence identical to a known splice acceptor site in a known gene, followed by; (v) an open reading frame encoding a known peptide tag recognizable by a known reaction characteristic of said known peptide tag, followed by; (vi) a nucleotide sequence selected from the group consisting of CAGGTAAGT, CAGGTGAGT, AAGGTAAGT, AAGGTGAG and any sequence identical to a known splice donor site in a known gene; (b) inserting said DNA sequence into said intron within said gene to create a tagged gene; and (2) incubating said tagged gene within a eucaryotic cell so as to maintain intact or to introduce said tagged gene within the genome of said eucaryotic cell, wherein during incubation said tagged gene is expressed producing said tagged protein; and (3) contacting said tagged protein with a binding reagent specific to said peptide tag such that said binding reagent binds to said tagged protein, and by means of the binding reagent, segregating said tagged protein from other constituents of the eucaryotic cell. 2. The method according to claim 1 wherein said method further comprises the step of characterizing a subcellular or extracellular structure of which said tagged protein is a constituent.

Details for Patent 6,080,541

Applicant	Tradename	Biologic Ingredient	Dosage Form	BLA	Approval Date	Patent No.	Expiredate
Merck Sharp & Dohme Corp.	INTRON A	interferon alfa-2b	For Injection	103132	06/04/1986		2013-01-05
Merck Sharp & Dohme Corp.	INTRON A	interferon alfa-2b	For Injection	103132			2013-01-05
Merck Sharp & Dohme Corp.	INTRON A	interferon alfa-2b	Injection	103132			2013-01-05